コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 cule derived from tetrahydro-3H-cyclopenta[c]quinoline.
2 substituents on the carboxylic A-ring of the quinoline.
3 d by a 5, 6, or 7 membered carbocycle to the quinoline.
4 d selectively the E-isomer of pyrimido[1,6-a]quinoline.
5 y the synthesis of pharmaceutically relevant quinolines.
6 ecently published results focused on related quinolines.
7 alkyl quinolines as well as more common aryl quinolines.
8 ing closure to yield hydroxynaphthalenes and quinolines.
9 rogenation of tetrahydroquinolines to afford quinolines.
10 paration of a number of medicinally relevant quinolines.
11 oration and hydrosilylation of pyridines and quinolines.
12 ons of N-(2-iodophenylsulfonyl)tetrahydroiso-quinolines.
13 3 led to better results for the synthesis of quinolines.
14 ccess a variety of 2-substituted indoles and quinolines.
15 tetrahydroquinolines into the corresponding quinolines.
18 design led to the identification of 3-pentyl-quinoline-2-amine as a novel, human TLR8-specific agonis
19 the kynurenic acid analog 7-chloro-4-oxo-1H-quinoline-2-carboxylic acid (7-chlorokynurenic acid; 7-C
24 n-3-yl]-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline -3-carboxamide; MQC) dose-dependently suppress
25 we show the synthesis of the tetrazolo[1,5-a]quinoline-3-carbaldehyde and tetrazolo[1,5-a]quinoline-3
26 -activity relationships, and binding mode of quinoline-3-carbohydrazide derivatives as allosteric mod
27 (4-methyl-1,4-diazepan-1- yl)sulfonyl)phenyl)quinoline-3-carbonitrile (NEU-924, 83) for T. cruzi and
28 1S)-1-(1-methyl-1H-pyrazol-3-yl)e thyl]amino}quinoline-3-carboxamide (74) as potent and highly select
30 edure for the synthesis of 2,4-unsubstituted quinoline-3-carboxylic acid ethyl esters is described.
31 quinoline-3-carbaldehyde and tetrazolo[1,5-a]quinoline-3-dimethyl acetal at room temperature in metha
32 rmacokinetic profile of 2,3,4-trisubstituted quinoline, 4, led to the discovery of two potent, select
33 ion of a phenotypic screening hit based on a quinoline-4-carboxamide derivative resulted in the highl
34 amoyl)-phenyl)-6,8-dimethyl-2-(pyridin-2- yl)quinoline-4-carboxamide], a selective GPR55 antagonist.
37 ising compounds led to the identification of quinoline 41 (RG7109), which was selected for advancemen
38 no-4-(4-fluorophenylamino)-1H-pyrazolo[4,3-c]quinoline (42) combined with chemotherapeutic CPT-11 tre
39 ioselective tandem synthesis of indolo[1,2-a]quinolines 4a-v and pyrrolo[1,2-a]quinolines 5a-k from 1
40 two compounds, 7-acetamido-2-(8'-quinolinyl)quinoline-5,8-dione (11) and 7-amino-2-(2-pyridinyl)quin
41 ne-5,8-dione (11) and 7-amino-2-(2-pyridinyl)quinoline-5,8-dione (23), showed selective cytotoxicity
43 of pore-size in a coordination network, [Cu(quinoline-5-carboxyate)2 ]n (Qc-5-Cu) ena+bles ultra-hig
44 azaguanine and 2-(2-(5-nitro-2-thienyl)vinyl)quinoline (5350150), which function by distinct mechanis
45 dolo[1,2-a]quinolines 4a-v and pyrrolo[1,2-a]quinolines 5a-k from 1-(2-bromophenyl)-1H-indole/pyrrole
46 ime, 10-dimethylamino derivatives of benzo[h]quinoline 6 and benzo[h]quinazoline 7a-e as mixed analog
47 n of a series of 7-oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamide derivatives as a novel chemotype
48 cation of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity
49 ture determination of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystallized with DYRK1A
50 -[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl )quinoline (8) was discovered from a highly selective hig
51 o-2,3-dihydro-1,4-dioxino[2,3-g]thieno[2,3-b]quinoline-8 -carboxamide (8), inhibited this interaction
52 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8- sulfonamide) have the combined properties o
53 p-tolyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4MP-TQS), together with all oth
54 n-2-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide ) and allosteric agonists such a
55 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide )] or an iodine atom [4IP-TQS (4
56 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide) ] generated a compound that lac
57 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide) and 3BP-TQS (4-(3-bromophenyl)-
58 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide) interact at an intrasubunit tra
59 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide), rather than at the para positi
60 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide)] results in compounds that have
61 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, is a strong positive allosteric
62 rylquinolines via Pd-catalyzed borylation of quinoline-8-yl halides and subsequent Suzuki-Miyaura cou
64 enyl ether affords 2-phenyl-3H-imidazo[4,5-b]quinoline-9-carbonitriles 15 in near quantitative yields
65 effect a three-component reaction between a quinoline, a terminal alkyne, and ethyl chloroformate.
66 ion of a variety of N-heteroarenes including quinolines, acridines, benzo[h], and 1,5-naphthyridine a
67 , we report on the effects of pyrazolo[4,3-c]quinolines acting as a new class of bacterial betaG-spec
69 f the pyrazole and amide substituents led to quinoline amide 21, which was advanced to preclinical de
71 ded to the synthesis and isotope labeling of quinoline and 1,2,3,4-tetrahydroquinoline derivatives.
73 licenes were synthesized utilizing versatile quinoline and 9-(2-ethylhexyl)-2,7-dimethoxycarbazole-3-
74 ABC transporter shown to be associated with quinoline and antifolate tolerance in Plasmodium falcipa
75 Potency was enhanced by methylation of the quinoline and by introduction of simple chiral moieties,
76 ew styryl dyes derived from 4-pyridine and 4-quinoline and having an ammonioalkyl N-substituent and b
77 s, revealing that high quantum yields of the quinoline and isoquinoline derivatives are a result of t
80 vity relationships (SAR) of a series of (iso)quinoline and quinazoline compounds that were synthesize
82 ular study revealed the necessity of hydroxy quinoline and the amine group for La(3+) ion binding and
83 tic aza-Michael/aldol cascade process toward quinolines and 1,4-dihydroquinolines depends on the choi
85 ch for the synthesis of 3-aryl-2-substituted quinolines and 4-arylacridines has been developed via th
86 ass of trans-fused hexahydro-1H-pyrano[3,4-c]quinolines and hexahydro-1H-thiopyrano[3,4-c]quinolines
87 strategy for the synthesis of pyrrolo[1,2-a]quinolines and indolizines from pyranoquinolines via sit
90 able, and practical synthesis of substituted quinolines and pyrimidines using combinations of 2-amino
91 and evaluated hitherto unexplored furo[2,3-c]quinolines and regioisomeric furo[3,2-c]quinolines deriv
92 erent polarities (naphthalene, acetophenone, quinoline, and 2-naphthol), and of the organocation para
93 lbenzofuran, dibenzofuran, dibenzothiophene, quinoline, and 6-methylquinoline were positive in the ER
96 sition metal-free acylation of isoquinoline, quinoline, and quinoxaline derivatives has been develope
97 lary SiNN pincer ligand that combines amido, quinoline, and silyl donors and gives rise to structural
98 lines in the presence of tert-butyl nitrite, quinoline, and the Sc(OTf)3 catalyst in DCE at 80 degree
99 tron-deficient N-heterocycles (isoquinoline, quinolines, and quinoxalines) and methylbenzenes leading
100 soquinoline derivatives differ from those of quinolines, and the most pronounced differences are foun
102 hts important implications for understanding quinoline antimalarial drug resistance and for future dr
104 has been accepted that a number of effective quinoline antimalarial drugs (e.g., chloroquine, quinine
105 d in situ surface observations and show that quinoline antimalarials inhibit beta-hematin crystal sur
106 tion, classical or nonclassical; and whether quinoline antimalarials inhibit crystallization by seque
108 ed sensitivity to chloroquine and some other quinoline antimalarials, but exhibit no or minimal chang
110 is and characterization of a triazole linked quinoline appended calix[4]arene conjugate, L, and its f
112 ium carbonate modified with lead acetate and quinoline are widely employed industrially for the parti
117 ges, but a piperazinyl group adjacent to the quinoline, at least for the group of compounds studied h
120 ilar pocket at the IN dimer interface as the quinoline-based ALLINIs, the lead compound, 5, inhibited
124 exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase le
125 een accomplished by using a combination of a quinoline-based ligand and a weakly coordinating amide d
132 2-benzothiazole-, 4-pyridine-, and 2- and 4-quinoline-based styryl dyes containing an N-methylbenzoa
133 cascade delivering a series of pyrrolo[1,2-a]quinolines bearing phosphonate or phosphine oxide moieti
134 rido[1,2-a] benzimidazole, benzimidazo[1,2-a]quinolines, benzimidazo [1,2-a]pyrazine, benzo[4,5] imid
135 described for the synthesis of various fused quinoline, benzoquinoline, and naphthoquinoline derivati
136 which was prepared from a readily available quinoline building block via Wittig reaction followed by
137 etrazolyl)quinolines or 1,2,3-triazolo[1,5-a]quinoline by conventional flash vacuum pyrolysis (FVP) w
139 ynthesis of 2-(1H-pyrrolo[2,3-b]pyridin-3-yl)quinolines by a SnCl(2)-catalyzed multicomponent reactio
140 epared a number of di- and trifunctionalized quinolines by selective metalation of chloro-substituted
141 action cascade to give ring-fused indoles B, quinolines C, or quinolones D depending on the reaction
142 odies a quaterpyridine backbone but with the quinoline C8 providing an additional sp(2) center separa
143 The NPAHs 1,4-dihydro(iso)quinoline and (iso)quinoline can be synthesized through reaction of pyridyl
144 ficantly decreasing the rotation rate of the quinoline-carbinol bond, the relatively bulky CF(3) grou
146 ecently we observed that the type II binding quinoline carboxamide (QCA) compounds were metabolically
150 this paper the identification of a nontoxic quinoline carboxylic acid that reverts the inhibition of
153 ivity in the regioselective hydrogenation of quinoline, compared with PtNPs of 5.3 nm, allowing the r
155 tilbene series, the 3,5,6,8-tetrasubstituted quinoline core was identified as replacement of the stil
161 strategy, a library of 5-methyl-indolo[3,2-c]quinoline derivatives (IQc) with a range of alkyldiamine
162 4-[(4-piperidinyl)methoxy]-2H-pyrrolo[3,4-c]quinoline derivatives as new 5-HT(4)R ligands endowed wi
164 of a new series of hexahydro-2H-pyrano[3,2-c]quinoline derivatives as potent sigma1 receptor (sigma1R
170 In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated
171 nternal alkynes proceeded smoothly to afford quinoline derivatives in good to excellent yields (up to
174 in 2-(2-vinylstyryl)oxazoles to form benzo[f]quinoline derivatives proceeds on the S1 PES via a stepw
175 strategies toward the synthesis of bioactive quinoline derivatives such as chloroquine analogues.
181 lled C(sp(3))-H arylation using pyridine and quinoline derivatives: The former promotes exclusive mon
182 the generation of a variety of indolo[2,3-b]quinolines derivatives in good to moderate yields with a
183 ,3-c]quinolines and regioisomeric furo[3,2-c]quinolines derived via a tandem, one-pot Sonogashira cou
184 ecently reported Suzuki coupling reaction of quinoline-derived allylic N,O-acetals has been studied u
185 amily of potential autophagy blockers is the quinoline-derived antimalarial family, including chloroq
186 hysicochemical properties of 5H-indolo[2,3-b]quinoline (DiMIQ), lipophilic and hemolytic properties w
189 is diversity shows that even closely related quinoline drugs may have quite different molecular pharm
190 alkaloid core is efficiently prepared from a quinoline, employing a method which relies on a newly de
191 prised of an NHS-carbamate reactive group, a quinoline fluorophore, and a tertiary amine for enhancin
193 lly, the one-pot multicomponent synthesis of quinolines from anilines, aldehydes, and olefins has als
194 gioselective synthesis of C-3-functionalized quinolines from azadienes (in situ generated from 2-amin
195 tandem synthesis of dihydroquinazolines and quinolines from N-alkylanilines using a TEMPO oxoammoniu
196 ation of 3-substituted and 3,4-disubstituted quinolines from stable starting materials (activated ace
198 as (ii) the presence of the nitrogen on the quinoline group, and (iii) of a hydrophobic group on the
199 lithium reagents to non-activated imines and quinolines has been accomplished in green, biorenewable
200 etrahydro-4,4-tetramethylene-1H-cyclopenta[c]quinolines have been obtained through the Skraup-Doebner
201 re active for reduction of a wide variety of quinolines having functionalities at the 2-, 6-, and 8-
202 II) ion detection reagent, 10-hydroxybenzo[h]quinoline (HBQ), with an optical field enhanced silicon
204 In this study, we identified the substituted quinoline HG-829 as a novel, noncompetitive, and potent
206 f 10 3-imidazo[1,2-a]pyridin-tetrazolo[1,5-a]quinolines in 28-94% yields via a novel one-pot Groebke-
207 quinolines and hexahydro-1H-thiopyrano[3,4-c]quinolines in good to excellent yields with high selecti
209 ding pyrimidines, N-substituted piperidines, quinolines, indoles, N-substituted imidazoles, triazoles
212 llowing HCAs: 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo-[4,5-f]quino
213 -IQ) formed by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a highly mutagenic and carcinogenic hete
218 es, azaindoles, deazapurines, benzimidazole, quinolines, isoquinolines, and pyridines were efficientl
221 covery of chiral acetyl-protected aminoethyl quinoline ligands that enable asymmetric palladium inser
226 ine (IQ), 2-amino-3,4-dimethylimidazo-[4,5-f]quinoline (MeIQ), 2-amino-3,8-dimethylimidazo-[4,5-f]qui
227 samides A-C are chlorinated pyrrolo[4,3,2-de]quinoline metabolites isolated from the marine-derived S
228 ly reported the therapeutic potential of the quinoline methanol Vacquinol-1 (1) that targets glioblas
230 omycin A derivatives consisting of different quinoline moieties covalently liked to a 15-membered aza
232 state places significant spin density on the quinoline moiety of the 1-isocyTPQA ligand positioned tr
233 ctor, it was shown that intercalation by the quinoline moiety of the ligand as assumed initially as t
237 o-triphenylmonoquinoline-annulated porphyrin quinoline N-oxide, possessing a slightly shifted and sha
239 lecular hydrogen bond between the protonated quinoline nitrogen (N(+)-H) and an imide carbonyl (O hor
240 between the phenol oxygen (proton donor) and quinoline nitrogen (proton acceptor), dO...N, giving ris
246 icient preparation of selected pyrrolo[1,2-a]quinolines on multigram scale without any safety concern
247 ethylquinolines generated from (5-tetrazolyl)quinolines or 1,2,3-triazolo[1,5-a]quinoline by conventi
249 ed for this reaction, such as isoquinolines, quinoline, phenanthridine, quinazoline, phthalazine, and
250 rid-2'-yl)-8-(1'',10''-phenanthrolin-2''-yl)-quinoline (ppq) embodies a quaterpyridine backbone but w
251 (1'',10''-phenanthrol-2''-yl)-2-(pyrid-2'-yl)quinoline (ppq), has been prepared by two sequential Fri
253 logy is further demonstrated in synthesis of quinoline-quinolone hybrid as well as 6-aryl-benzofuro[3
254 The reaction uses 2-(4,5-dihydro-2-oxazolyl)quinoline (quinox) as a ligand and is performed at ambie
255 The reaction uses 2-(4,5-dihydro-2-oxazolyl)quinoline (Quinox) as ligand and TBHP(aq) as oxidant to
256 iosynthesized by (18)F-introduction onto the quinoline rather than the pyrazole moiety of the MP-10 p
258 vealed that the geometric disposition of the quinoline ring at the C8 chiral carbon of cinchona-enami
259 to the phenyl group at the 4-position of the quinoline ring of tipifarnib and by replacing the amino
260 g through the adjacent carbonyl group on the quinoline ring resulted in successful predictions of obs
261 AR) of the 4-, 6-, and 8-substituents of the quinoline ring resulted in the identification of approxi
262 an annulation in the final step to close the quinoline ring, leading to a dihydroquinoline derivative
264 ry of PSI-697 (1a), a C-2 benzyl substituted quinoline salicylic acid-based P-selectin inhibitor.
266 design of this series centered on morphing a quinoline series recently disclosed in the patent litera
267 Compounds with a quaternary nitrogen on the quinoline show improved activity against the chloroquine
268 oups with respect to both the alkyne and the quinoline starting materials and the products are easily
269 s all contain a 2-methyl-4-amino-6,7-dioxolo-quinoline structure that is predicted from the modeling
271 reement with some of the previously reported quinoline syntheses, an alternative mechanistic pathway
272 l mechanism of the Skraup-Doebner-Von Miller quinoline synthesis remains controversial and not well u
275 first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicoche
276 as palladium-catalyzed coupling to generate quinolines that can be substituted at every position of
279 oaddition, using sulfonyl azide, alkyne, and quinoline, to prepare pyrimido[1,6-a]quinolines is repor
281 component Povarov reaction forms 2,3-dialkyl quinolines under the same green conditions that enable t
282 eous iridium catalyst gives hydrogenation of quinolines under unprecedentedly mild conditions-as low
283 15a-g, a regioisomer of the bisindolo[1,2-a]quinolines used as organic single-crystal field-effect t
285 he synthesis of densely substituted 4-alkoxy quinolines via an oxonium ion triggered alkyne carboamin
286 (4-(2,4-dinitrophenylsulfonyl)piperazin-1-yl)quinoline (VR23) as a small molecule that potently inhib
288 iodo-substituted tetrahydro-3H-cyclopenta[c]quinolines was synthesized as potential targeted imaging
290 edlander and Combes syntheses of substituted quinolines were conducted in charged microdroplets produ
291 A series of 18 3-tetrazolyl-tetrazolo[1,5-a]quinolines were synthesized in 21-90% yields via a novel
292 d N10,O11-bis-alkylamine (3a-k) indolo[3,2-b]quinolines, were evaluated for their in vitro activity a
293 d a new displacer, 4-methyl-2-piperazin-1-yl-quinoline, which produced a more selective displacement
295 y selective metalation of chloro-substituted quinolines with metal amides followed by reaction with d
296 reaction of [(bzq)Pd(OAc)](2) (bzq = benzo[h]quinoline) with "CF(3)(+)" reagents to afford the monome
297 nistic activity profile in select furo[2,3-c]quinolines, with maximal potency conferred by a C2-butyl
299 cluding Tartrazine (E102), Chrysoine (E103), Quinoline Yellow (E104), Yellow 2G (E107), Sunset Yellow
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。